Focused Ultrasound Shows Effective Against Glioblastoma
By MedImaging International staff writers Posted on 29 Jun 2020 |
Combining 5-ALA, a drug that sensitizes cancer to sound waves, and focused ultrasound is far more effective than either alone in killing glioblastoma cells, claims a new study.
Under investigation by researchers at the University of Virginia Health Sciences Center (Charlottesville, USA) and Fondazione IRCCS Istituto Neurologico C. Besta (Milan, Italy), sonodynamic therapy (SDT) is an emerging modality for cancer treatment which combines ultrasound with sonosensitizers to produce a localized cytotoxic effect. The aim of the study was to demonstrate the efficacy of SDT with fluorescein (FL) and low-intensity focused ultrasound in inhibiting the growth of ectopic gliomas implanted in a rat’s subcutaneous tissue.
For the study, in vivo cytotoxicity of FL-SDT was evaluated in C6 rat glioma cells which were inoculated subcutaneously. They then examined the benefits of 5-ALA and focused ultrasound, both individually and in combination, and found that the pairing was far more effective than either alone. While the drug alone reduced the number of viable cancer cells by 5%, focused ultrasound reduced it by 16%. Together, the reduction was 47%. The study was published on June 4, 2020, in the Journal of Neuro-Oncology.
“Sonodynamic therapy with focused ultrasound offers a new therapeutic approach to treating patients with malignant brain tumors,” said study co-author neurosurgeon Jason Sheehan, MD, PhD, of UVA Health. ""Focused ultrasound has the potential to improve outcomes for patients with complex brain tumors and other neurosurgical pathologies. We may be at the tip of the iceberg in terms of intracranial indications for focused ultrasound.”
Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.
Related Links:
University of Virginia Health Sciences Center
Fondazione IRCCS Istituto Neurologico C. Besta
Under investigation by researchers at the University of Virginia Health Sciences Center (Charlottesville, USA) and Fondazione IRCCS Istituto Neurologico C. Besta (Milan, Italy), sonodynamic therapy (SDT) is an emerging modality for cancer treatment which combines ultrasound with sonosensitizers to produce a localized cytotoxic effect. The aim of the study was to demonstrate the efficacy of SDT with fluorescein (FL) and low-intensity focused ultrasound in inhibiting the growth of ectopic gliomas implanted in a rat’s subcutaneous tissue.
For the study, in vivo cytotoxicity of FL-SDT was evaluated in C6 rat glioma cells which were inoculated subcutaneously. They then examined the benefits of 5-ALA and focused ultrasound, both individually and in combination, and found that the pairing was far more effective than either alone. While the drug alone reduced the number of viable cancer cells by 5%, focused ultrasound reduced it by 16%. Together, the reduction was 47%. The study was published on June 4, 2020, in the Journal of Neuro-Oncology.
“Sonodynamic therapy with focused ultrasound offers a new therapeutic approach to treating patients with malignant brain tumors,” said study co-author neurosurgeon Jason Sheehan, MD, PhD, of UVA Health. ""Focused ultrasound has the potential to improve outcomes for patients with complex brain tumors and other neurosurgical pathologies. We may be at the tip of the iceberg in terms of intracranial indications for focused ultrasound.”
Focused ultrasound is based on nonlinear acoustic mathematical optimization methods to analyze and simulate the propagation of sound in material. The information is then used to enhance the shape of an acoustic lens in such a way that that ultrasound pressure is focused precisely on the location of the tissue to be treated, while the surrounding tissue retains as little damage as possible.
Related Links:
University of Virginia Health Sciences Center
Fondazione IRCCS Istituto Neurologico C. Besta
Latest Ultrasound News
- Groundbreaking Technology Enables Precise, Automatic Measurement of Peripheral Blood Vessels
- Deep Learning Advances Super-Resolution Ultrasound Imaging
- Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
- AI-Guided Ultrasound System Enables Rapid Assessments of DVT
- Focused Ultrasound Technique Gets Quality Assurance Protocol
- AI-Guided Handheld Ultrasound System Helps Capture Diagnostic-Quality Cardiac Images
- Non-Invasive Ultrasound Imaging Device Diagnoses Risk of Chronic Kidney Disease
- Wearable Ultrasound Platform Paves Way for 24/7 Blood Pressure Monitoring On the Wrist
- Diagnostic Ultrasound Enhancing Agent to Improve Image Quality in Pediatric Heart Patients
- AI Detects COVID-19 in Lung Ultrasound Images
- New Ultrasound Technology to Revolutionize Respiratory Disease Diagnoses
- Dynamic Contrast-Enhanced Ultrasound Highly Useful For Interventions
- Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis
- Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images
- Ultrasound Imaging Technology Allows Doctors to Watch Spinal Cord Activity during Surgery
- Shape-Shifting Ultrasound Stickers Detect Post-Surgical Complications